NCT00002366View on ClinicalTrials.gov

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Ritonavir

Trial Locations (2)

Unknown

Prince Henry's Hosp / Med Oncology, Sydney

Saint Vincent's Hosp Med Centre, Sydney

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00002366 - The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter